JAK2 and thoracolaryngopelvic dysplasia: It is possible that STAT3-JAK2 fusion gene promotes transition to aggressive T cell lymphoma as one of 5 CD4+ GI T-LPD case with the fusion protein was reported to develop T-cell lymphoma (16).